Post-Transplantation Lymphoproliferative Disorders Solid-organ and hematopoietic stem-
cell transplants are widely used for various life-threatening medical disorders. Prophylaxis …

Post-transplant lymphoproliferative diseases (PTLD) are heterogeneous lymphoid disorders
ranging from indolent polyclonal proliferations to aggressive lymphomas that complicate …

These updated guidelines from the American Society of Transplantation Infectious Diseases
Community of Practice review the diagnosis, management, and prevention of post …

Summary Background Survival in Epstein–Barr virus (EBV)-positive post-transplant
lymphoproliferative disease following haematopoietic stem-cell transplant (HSCT) or solid …

This updated section of the guideline from the Infectious Diseases Community of Practice of
the American Society of Transplantation reviews the screening of donor and candidate prior …

Post-transplant lymphoproliferative diseases (PTLD) associated with Epstein-Barr virus
(EBV) infection often develop after organ and haematopoietic stem-cell transplantation …

Post-transplant lymphoproliferative disorders (PTLDs) are a group of conditions that involve
uncontrolled proliferation of lymphoid cells as a consequence of extrinsic …

Posttransplant lymphoproliferative disorder (PTLD) is recognized as potentially one of the
most devastating complications of organ transplantation. The Epstein–Barr virus (EBV) …

Posttransplant lymphoproliferative disease (PTLD) is a potentially fatal complication after
(solid organ) transplantation, which is highly associated with Epstein-Barr virus (EBV). The …

Transplant recipients are vulnerable to a higher risk of malignancy after solid organ
transplantation and allogeneic hematopoietic stem-cell transplant. Post-transplant …